Literature DB >> 25623537

miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.

Chuanyi Zhou1, Liangfang Shen2, Lei Mao3, Bing Wang3, Yang Li3, Huizhi Yu3.   

Abstract

MicroRNAs (miRNAs) are involved in the cervical carcinogenesis and progression. In this study, we investigated the role of miR-92a in progression and invasion of cervical cancer. MiR-92a was significantly upregulated in cervical cancer tissues and cell lines. Overexpression of miR-92a led to remarkably enhanced proliferation by promoting cell cycle transition from G1 to S phase and significantly enhanced invasion of cervical cancer cells, while its knockdown significantly reversed these cellular events. Bioinformatics analysis suggested F-box and WD repeat domain-containing 7 (FBXW7) as a novel target of miR-92a, and miR-92a suppressed the expression level of FBXW7 mRNA by direct binding to its 3'-untranslated region (3'UTR). Expression of miR-92a was negatively correlated with FBXW7 in cervical cancer tissues. Furthermore, Silencing of FBXW7 counteracted the effects of miR-92a suppression, while its overexpression reversed oncogenic effects of miR-92a. Together, these findings indicate that miR-92a acts as an onco-miRNA and may contribute to the progression and invasion of cervical cancer, suggesting miR-92a as a potential novel diagnostic and therapeutic target of cervical cancer.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; FBXW7; Invasion; Proliferation; miR-92a

Mesh:

Substances:

Year:  2015        PMID: 25623537     DOI: 10.1016/j.bbrc.2015.01.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

Review 1.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

2.  MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.

Authors:  Hao Chang; Yue-Hong Liu; Li-Li Wang; Ju Wang; Zhi-Hong Zhao; Jun-Feng Qu; Sheng-Fa Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

3.  Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia.

Authors:  M Sharifi; R Salehi
Journal:  Cancer Gene Ther       Date:  2015-12-11       Impact factor: 5.987

4.  BMP9-induced osteogenic differentiation is partially inhibited by miR-30a in the mesenchymal stem cell line C3H10T1/2.

Authors:  Ruyi Zhang; Yaguang Weng; Baolin Li; Yingjiu Jiang; Shujuan Yan; Fang He; Xiaoqing Chen; Fang Deng; Jing Wang; Qiong Shi
Journal:  J Mol Histol       Date:  2015-07-24       Impact factor: 2.611

5.  MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3β and activating Wnt signaling in bladder cancer cells.

Authors:  Haifeng Wang; Changxing Ke; Xingyong Ma; Qinghua Zhao; Mingying Yang; Wei Zhang; Jiansong Wang
Journal:  Tumour Biol       Date:  2016-11-09

Review 6.  MicroRNA regulation of F-box proteins and its role in cancer.

Authors:  Zhao-Hui Wu; Lawrence M Pfeffer
Journal:  Semin Cancer Biol       Date:  2015-10-01       Impact factor: 15.707

7.  MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3.

Authors:  Shengtian Luo; Na Li; Shaohua Yu; Lichun Chen; Chunying Liu; Jiawei Rong
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

8.  MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7.

Authors:  Chi-Hsiang Chiang; Pei-Yi Chu; Ming-Feng Hou; Wen-Chun Hung
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

9.  Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.

Authors:  Yue Xu; Shuhua Zhao; Manhua Cui; Qiang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Expression and prognostic value of miR-92a in patients with gastric cancer.

Authors:  Chuanli Ren; Wenshu Wang; Chongxu Han; Hui Chen; Deyuan Fu; Yulin Luo; Hanyu Yao; Daxin Wang; Li Ma; Lin Zhou; Dongsheng Han; Ming Shen
Journal:  Tumour Biol       Date:  2016-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.